Variant report
Variant | rs418260 |
---|---|
Chromosome Location | chr21:46012524-46012525 |
allele | C/T |
Outlinks | Ensembl   UCSC |
- TF binding region (count:2)
- CpG islands (count:61)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:2 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | YY1 | chr21:46012306-46012726 | ECC-1 | luminal epithelium: | n/a | n/a |
2 | TCF12 | chr21:46012275-46012963 | ECC-1 | luminal epithelium: | n/a | chr21:46012677-46012687 |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr21:46012520-46012570 | HCF | heart: | n/a |
2 | chr21:46012520-46012570 | IMR90 | lung: | fetal |
3 | chr21:46012520-46012570 | HCT-116 | colon: | n/a |
4 | chr21:46012520-46012570 | Hela-S3 | cervix: | n/a |
5 | chr21:46012520-46012570 | ovcar-3 | ovarian: | n/a |
6 | chr21:46012520-46012570 | Hepatocyte | liver: | n/a |
7 | chr21:46012520-46012570 | HCPEpiC | choroid plexus: | n/a |
8 | chr21:46012520-46012570 | CMK | blood: | n/a |
9 | chr21:46012520-46012570 | RPTEC | kidney: | n/a |
10 | chr21:46012520-46012570 | AG04450 | lung: | fetal |
11 | chr21:46012520-46012570 | NB4 | blood: | n/a |
12 | chr21:46012520-46012570 | PrEC | prostate: | n/a |
13 | chr21:46012520-46012570 | HMEC | breast: | n/a |
14 | chr21:46012520-46012570 | SK-N-MC | brain: | n/a |
15 | chr21:46012520-46012570 | HPAEpiC | pulmonary alveolar: | n/a |
16 | chr21:46012520-46012570 | Caco-2 | colon: | n/a |
17 | chr21:46012520-46012570 | AG09319 | gingival: | n/a |
18 | chr21:46012520-46012570 | GM06990 | blood: | n/a |
19 | chr21:46012520-46012570 | T-47D | breast: | n/a |
20 | chr21:46012520-46012570 | HIPEpiC | eye: | n/a |
21 | chr21:46012520-46012570 | HL-60 | blood: | n/a |
22 | chr21:46012520-46012570 | BJ | skin: | n/a |
23 | chr21:46012520-46012570 | HEEpiC | esophagus: | n/a |
24 | chr21:46012520-46012570 | HepG2 | liver: | n/a |
25 | chr21:46012520-46012570 | BE2_C | brain: | n/a |
26 | chr21:46012520-46012570 | SK-N-SH_RA | brain: | n/a |
27 | chr21:46012520-46012570 | HEK293 | kidney: | embryo |
28 | chr21:46012520-46012570 | AoSMC | blood vessel: | n/a |
29 | chr21:46012520-46012570 | NHDF-neo | bronchial: | n/a |
30 | chr21:46012520-46012570 | H1-hESC | embryonic stem cell: | embryo |
31 | chr21:46012520-46012570 | HNPCEpiC | eye: | n/a |
32 | chr21:46012520-46012570 | HCM | heart: | n/a |
33 | chr21:46012520-46012570 | LNCaP | prostate: | n/a |
34 | chr21:46012520-46012570 | ProgFib | skin: | n/a |
35 | chr21:46012520-46012570 | PANC-1 | pancreas: | n/a |
36 | chr21:46012520-46012570 | K562 | blood: | n/a |
37 | chr21:46012520-46012570 | GM12892 | blood: | n/a |
38 | chr21:46012520-46012570 | AG10803 | skin: | n/a |
39 | chr21:46012520-46012570 | MCF10A-Er-Src | breast: | n/a |
40 | chr21:46012520-46012570 | NHBE | bronchial: | n/a |
41 | chr21:46012520-46012570 | GM12878 | blood: | n/a |
42 | chr21:46012520-46012570 | AG04449 | skin: | fetal |
43 | chr21:46012520-46012570 | NT2-D1 | testis: | n/a |
44 | chr21:46012520-46012570 | SKMC | muscle: | n/a |
45 | chr21:46012520-46012570 | HRE | kidney: | n/a |
46 | chr21:46012520-46012570 | MCF-7 | breast: | n/a |
47 | chr21:46012520-46012570 | HRCEpiC | kidney: | n/a |
48 | chr21:46012520-46012570 | PFSK-1 | brain: | n/a |
49 | chr21:46012520-46012570 | NH-A | brain: | n/a |
50 | chr21:46012520-46012570 | HAEpiC | amniotic membrane: | n/a |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr21:46010036..46012728-chr21:46031362..46034012,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
KRTAP10-6 | TF binding region |
KRTAP10-6 | CpG island |
ENSG00000187766 | Chromatin interaction |
rs_ID | r2[population] |
---|---|
rs1211061 | 0.87[CHB][hapmap] |
rs1211088 | 1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[CHD][hapmap];0.92[GIH][hapmap];1.00[JPT][hapmap];0.82[MEX][hapmap];0.82[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs1211089 | 1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];0.88[AMR][1000 genomes];0.82[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs1211103 | 1.00[CHB][hapmap];1.00[JPT][hapmap];0.82[MEX][hapmap];0.93[ASN][1000 genomes] |
rs1211118 | 0.87[ASN][1000 genomes] |
rs1211121 | 1.00[CHB][hapmap];1.00[JPT][hapmap];0.87[ASN][1000 genomes] |
rs1211122 | 0.87[ASN][1000 genomes] |
rs1211123 | 0.93[CHB][hapmap];1.00[JPT][hapmap];0.89[ASN][1000 genomes] |
rs12627104 | 0.92[ASN][1000 genomes] |
rs12627414 | 1.00[CHB][hapmap];1.00[JPT][hapmap];0.82[MEX][hapmap];0.87[ASN][1000 genomes] |
rs170849 | 1.00[MEX][hapmap] |
rs2226687 | 1.00[MEX][hapmap] |
rs233268 | 0.82[MEX][hapmap] |
rs233272 | 0.82[MEX][hapmap] |
rs233298 | 0.89[ASN][1000 genomes] |
rs233299 | 0.88[ASN][1000 genomes] |
rs233300 | 0.80[EUR][1000 genomes];0.92[ASN][1000 genomes] |
rs2838598 | 0.94[CHB][hapmap];0.82[MEX][hapmap] |
rs366534 | 0.95[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs367771 | 0.81[CHB][hapmap] |
rs369111 | 0.85[CHB][hapmap] |
rs369720 | 0.83[ASN][1000 genomes] |
rs370092 | 0.94[CHB][hapmap];1.00[JPT][hapmap];0.92[ASN][1000 genomes] |
rs371248 | 1.00[CHB][hapmap];1.00[JPT][hapmap] |
rs377234 | 1.00[CHB][hapmap];0.86[CHD][hapmap];0.80[GIH][hapmap];1.00[JPT][hapmap];0.82[MEX][hapmap];0.97[ASN][1000 genomes] |
rs377573 | 0.83[AMR][1000 genomes];0.97[ASN][1000 genomes] |
rs379858 | 0.87[CHB][hapmap] |
rs382935 | 1.00[CHB][hapmap];0.80[GIH][hapmap];1.00[JPT][hapmap];0.82[MEX][hapmap];0.87[ASN][1000 genomes] |
rs384645 | 1.00[CHB][hapmap];1.00[JPT][hapmap];0.92[ASN][1000 genomes] |
rs385033 | 0.92[ASN][1000 genomes] |
rs389936 | 0.82[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs392451 | 1.00[CHB][hapmap];1.00[JPT][hapmap];0.97[ASN][1000 genomes] |
rs392686 | 0.94[CHB][hapmap];0.80[GIH][hapmap];0.82[MEX][hapmap] |
rs398680 | 1.00[CHB][hapmap];0.80[GIH][hapmap];1.00[JPT][hapmap];0.82[MEX][hapmap];0.92[ASN][1000 genomes] |
rs400170 | 0.82[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs400368 | 0.87[CHB][hapmap] |
rs400406 | 1.00[CEU][hapmap];0.84[JPT][hapmap] |
rs403981 | 1.00[CHB][hapmap];0.87[CHD][hapmap];0.80[GIH][hapmap];1.00[JPT][hapmap];0.82[MEX][hapmap];0.97[ASN][1000 genomes] |
rs404341 | 1.00[CHB][hapmap];0.87[CHD][hapmap];0.80[GIH][hapmap];1.00[JPT][hapmap];0.82[MEX][hapmap];0.97[ASN][1000 genomes] |
rs408285 | 0.93[ASN][1000 genomes] |
rs408516 | 0.82[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs408958 | 0.94[CHB][hapmap] |
rs409893 | 1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];0.82[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs411254 | 0.86[JPT][hapmap];1.00[MEX][hapmap] |
rs415753 | 0.94[CHB][hapmap] |
rs416056 | 1.00[CHB][hapmap];1.00[JPT][hapmap];0.97[ASN][1000 genomes] |
rs417538 | 1.00[CHB][hapmap];1.00[JPT][hapmap];0.97[ASN][1000 genomes] |
rs430609 | 0.87[CHB][hapmap] |
rs434716 | 0.87[CHB][hapmap] |
rs437149 | 0.92[ASN][1000 genomes] |
rs437371 | 0.92[EUR][1000 genomes] |
rs438444 | 1.00[CEU][hapmap] |
rs442110 | 0.85[ASN][1000 genomes] |
rs442226 | 1.00[CHB][hapmap];1.00[JPT][hapmap];0.92[ASN][1000 genomes] |
rs442761 | 0.93[ASN][1000 genomes] |
rs442849 | 0.82[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs445214 | 0.86[JPT][hapmap];0.82[MEX][hapmap] |
rs446817 | 0.90[ASN][1000 genomes] |
rs447568 | 0.82[ASN][1000 genomes] |
rs452002 | 1.00[CHB][hapmap];0.80[GIH][hapmap];1.00[JPT][hapmap];0.82[MEX][hapmap];0.91[ASN][1000 genomes] |
rs452547 | 0.97[ASN][1000 genomes] |
rs455413 | 0.87[CHB][hapmap] |
rs455562 | 0.87[CHB][hapmap] |
rs455714 | 0.87[CHB][hapmap] |
rs455777 | 0.87[CHB][hapmap] |
rs455906 | 1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];0.94[AMR][1000 genomes];0.85[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs456019 | 0.82[MEX][hapmap] |
rs456444 | 0.87[CHB][hapmap] |
rs457322 | 0.87[CHB][hapmap] |
rs459644 | 1.00[CEU][hapmap];0.92[GIH][hapmap] |
rs459845 | 0.87[CHB][hapmap] |
rs459915 | 0.87[CHB][hapmap] |
rs460064 | 0.87[CHB][hapmap] |
rs460085 | 0.87[CHB][hapmap] |
rs460122 | 0.87[CHB][hapmap] |
rs462254 | 0.87[CHB][hapmap] |
rs463239 | 0.87[CHB][hapmap] |
rs463267 | 0.87[CHB][hapmap] |
rs463668 | 0.87[CHB][hapmap] |
rs463876 | 0.80[EUR][1000 genomes] |
rs464281 | 0.87[CHB][hapmap] |
rs464504 | 0.87[CHB][hapmap] |
rs464684 | 0.87[CHB][hapmap] |
rs465930 | 0.87[CHB][hapmap] |
rs466094 | 0.87[CHB][hapmap] |
rs466628 | 0.80[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs487102 | 1.00[MEX][hapmap] |
rs56274513 | 0.88[ASN][1000 genomes] |
rs58029281 | 0.80[ASN][1000 genomes] |
rs58757665 | 0.98[ASN][1000 genomes] |
rs659638 | 1.00[CHB][hapmap];0.80[GIH][hapmap];1.00[JPT][hapmap];0.82[MEX][hapmap];0.92[ASN][1000 genomes] |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | esv33817 | chr21:45169412-46031810 | Weak transcription Bivalent/Poised TSS Enhancers Flanking Active TSS Strong transcription Genic enhancers Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 121 gene(s) | inside rSNPs | diseases |
2 | esv3361489 | chr21:45669073-46013747 | Weak transcription Enhancers Flanking Active TSS Strong transcription Active TSS Bivalent Enhancer ZNF genes & repeats Flanking Bivalent TSS/Enh Genic enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 69 gene(s) | inside rSNPs | diseases |
3 | nsv913943 | chr21:45740823-46031810 | Enhancers Bivalent Enhancer Active TSS Flanking Active TSS Strong transcription Weak transcription Genic enhancers ZNF genes & repeats Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 52 gene(s) | inside rSNPs | diseases |
4 | nsv913946 | chr21:45838632-46031810 | Bivalent Enhancer ZNF genes & repeats Active TSS Enhancers Weak transcription Strong transcription Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS Genic enhancers Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 34 gene(s) | inside rSNPs | diseases |
5 | nsv913948 | chr21:45860912-46031810 | Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS Active TSS Strong transcription Genic enhancers Flanking Bivalent TSS/Enh ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 29 gene(s) | inside rSNPs | diseases |
6 | nsv1056424 | chr21:45894901-46031810 | Weak transcription Enhancers Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer ZNF genes & repeats Active TSS Flanking Bivalent TSS/Enh Strong transcription Genic enhancers Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 24 gene(s) | inside rSNPs | diseases |
7 | nsv544475 | chr21:45894901-46031810 | Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats Weak transcription Active TSS Genic enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Strong transcription | TF binding regionCpG islandChromatin interactive regionlncRNA | 24 gene(s) | inside rSNPs | diseases |
8 | nsv1055163 | chr21:45895663-46031810 | Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription Active TSS Bivalent/Poised TSS Strong transcription Genic enhancers Flanking Bivalent TSS/Enh ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 24 gene(s) | inside rSNPs | diseases |
9 | nsv1065798 | chr21:45941000-46097463 | Flanking Active TSS Bivalent Enhancer Enhancers Weak transcription ZNF genes & repeats Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Strong transcription | TF binding regionCpG islandChromatin interactive regionlncRNA | 21 gene(s) | inside rSNPs | diseases |
10 | nsv869108 | chr21:45941000-46097463 | Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS ZNF genes & repeats Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Genic enhancers Strong transcription | TF binding regionCpG islandChromatin interactive regionlncRNA | 21 gene(s) | inside rSNPs | diseases |
11 | nsv544476 | chr21:45941000-46097463 | Bivalent Enhancer Flanking Active TSS Enhancers Weak transcription ZNF genes & repeats Genic enhancers Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Strong transcription | TF binding regionCpG islandChromatin interactive regionlncRNA | 21 gene(s) | inside rSNPs | diseases |
12 | nsv913951 | chr21:45985068-46012524 | Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS ZNF genes & repeats Active TSS Flanking Bivalent TSS/Enh Genic enhancers | TF binding regionCpG islandChromatin interactive regionlncRNA | 6 gene(s) | inside rSNPs | diseases |
13 | nsv913950 | chr21:45985068-46097463 | Genic enhancers Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription ZNF genes & repeats Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 18 gene(s) | inside rSNPs | diseases |
14 | nsv913952 | chr21:45988426-46031810 | Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Genic enhancers ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNA | 8 gene(s) | inside rSNPs | diseases |
15 | esv2751931 | chr21:45990446-46031810 | Enhancers Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Genic enhancers ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNA | 7 gene(s) | inside rSNPs | diseases |
16 | nsv587810 | chr21:45992131-46031810 | Enhancers Weak transcription Bivalent Enhancer Active TSS Flanking Active TSS ZNF genes & repeats Genic enhancers Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 7 gene(s) | inside rSNPs | diseases |
17 | nsv916258 | chr21:45995986-46624705 | Weak transcription Enhancers Flanking Active TSS Strong transcription Genic enhancers Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 102 gene(s) | inside rSNPs | diseases |
18 | esv3360675 | chr21:46010349-46012897 | Enhancers Bivalent Enhancer Weak transcription ZNF genes & repeats | TF binding regionCpG islandChromatin interactive region | 2 gene(s) | inside rSNPs | diseases |
19 | nsv913953 | chr21:46012524-46031810 | ZNF genes & repeats Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS Genic enhancers | TF binding regionCpG islandChromatin interactive region | 4 gene(s) | inside rSNPs | diseases |
No data |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr21:45998800-46012800 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
2 | chr21:46002400-46018200 | Weak transcription | Right Atrium | heart |
3 | chr21:46011000-46012600 | Enhancers | Fetal Muscle Leg | muscle |
4 | chr21:46011200-46013200 | Enhancers | HepG2 | liver |
5 | chr21:46011400-46012600 | Weak transcription | H1 Cell Line | embryonic stem cell |
6 | chr21:46011400-46014000 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
7 | chr21:46011400-46014000 | Bivalent Enhancer | Skeletal Muscle Male | skeletal muscle |
8 | chr21:46011400-46014400 | Enhancers | Liver | Liver |
9 | chr21:46011600-46013000 | Enhancers | Esophagus | oesophagus |
10 | chr21:46012000-46013400 | Weak transcription | HMEC | breast |
11 | chr21:46012200-46014000 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
12 | chr21:46012200-46014000 | Enhancers | Placenta | Placenta |
13 | chr21:46012200-46014200 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
14 | chr21:46012200-46014400 | Bivalent Enhancer | Fetal Muscle Trunk | muscle |
15 | chr21:46012400-46012800 | Bivalent Enhancer | Foreskin Fibroblast Primary Cells skin01 | Skin |
16 | chr21:46012400-46012800 | Enhancers | Spleen | Spleen |
17 | chr21:46012400-46013600 | Bivalent Enhancer | Fetal Stomach | stomach |
18 | chr21:46012400-46014600 | Enhancers | HUES6 Cell Line | embryonic stem cell |